Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Oh. Makes sense. Thx
Agree. Some very big contracts should be inked later this year once Gen3 is fully online. Also we will hear from Aspire in the fall on their contract awards.
If P has good data. Add the fact there are zero ties to ownership or patent issues. It is 100% owned by IPIX. It also comes with the 505 b2 designation. This could give the owner up to 5 more years of exclusivity. That's at the end of the already great patent. Those facts are priceless and will increase BPs offer if a buyout occurs.
Jmo
I love reading that. Makes you think! Could results be PRd tomorrow? Could those 6 week results be SIGNIFICANT and blow all expectations out of the water? Possibilities are why we are here my friend. Here is to one day!
Thank you! Great read. This is exactly why I read iHub boards.
Excellent update
1-2 billion at this time fully diluted is between 6.25-12.50. A share
Really good understanding and well written. Thank you.
Per Dr B. A BP will pay what they believe the drug is worth. In their minds and their evaluation. There is no conspiracy theory. There is no trying to take out legs. BP will empty their pockets when the time is right.
For all we know, IPIX mgmt is taking this company to a full buyOut, none of us know.
All we do know.......is that the drugs are extremely valuable and the data so far has been nothing but exceptional. (Extremely valuable based on market and indications)
Congrats to all for holding IPIX. There is no doubt this will be 100x move at some point.
There are things that these people don't understand. The basics, like P is 100% owned by IPIX. The word FIRST IN CLASS, the formulation and cost of manufacturing, the FDA designations....I could go on, but it's things you already know.
These basics of IPIX sets it above the rest. IPIX is unknown as of today. So it's a huge discount.
There is actually no doubt this company is worth 5xs current share price. Right now.
B-OM or P will knock the dust off. Imo. No doubt.
Remember 2012. We had zero cash-zero financing - zero human trials. Share price was above today.
Today. Millions in cash, 10's of millions in financing, 5 or 6 successful human trials. 3 active human late stage trials.
We should have ATLEAST a 4-5 dollar share price today. IMO.
Our deal and day is a day closer as the next day ends. It is impossible not to ink a deal with our pipeline. The only question, which one or will it be for the whole company? P an B is the race imo.
Great post. Thanks for facts. One day a deal will be made, until then I keep adding.
We will win! Big time. IMO.
Where is the update that was said to be out in "days" about 2 weeks ago?
Just saying. Let's go company
BREAKTHROUGH DESIGNATION plus ROLLING REVIEW imo.
Only a couple months to that but K and P updates prior imo.
Maybe a partnership announcement too
I do not either.
Got the same thing. These boards are looking to spin anything. We will be laughing last. This is a top tier company with the best first in class drugs in the biotech industry. Time is all we need. Watching the sunset is phenomenal.
As I read some updates on other Nasdaq biotechs....it's amazing how well IPIX is doing in trials and the share price does not react. The day we get a partner or cash and the day we have national coverage we are going to FLY!!!! Our science trumps everything I read and those stocks go up 60% in a day on mediocre updates in comparison with IPIX.
Our day will come
I'm in the Pfizer camp myself. We have a ways to go, but looking to be RIGHT ON TARGET!
B-om - only preventative drug (possibly)
B-up/crohns/uc/all ibd (possibly)
B-absssi - already compared to a blockbuster.
B-acne and HS
B-topical for diabetic ulcers and possible topical for implants
Eye and ear----more to come
If that is not worth ATLEAST 11billion buyout. Someone is high.
We just need some data on OM.
Say b was able to control market share in just 2 of the above and make dents in all other market share above.....how many billions a year could b make? 17 billion a year? Pushing Humira?
11billion would be garage sale red light sale. Pfizer would be a genius and make shareholders very profitable. IMO
There is only over a million plus short right? Imagine those million short if B was sold tomorrow for 11 billion?
Share price would be over 70 plus in a blink. That would bankrupt some
Yes! If the data keeps up at this strong positive pace: there is no choice for BP to ante up and pay big dollars. Investors in those BPs want blockbusters and we could have 3
I looked earlier today and I thought the secondary outcomes and followup went 11 weeks. I was in rush tho while looking
It is 11 weeks boss. Should be done around Oct 23rd if the final patient began dosing today. And then collection of data etc.... I'd say in December some time. Jmo.
Great PR today. Not one I expected. I can bet that the unbelievable small data set for the interim helped spark patient interest and enrollment. I mean we flew the final 9 months. This trial has been a long one, but anytime cancer is involved....it seems to be the case.
GREAT NEWs. And could be the first partner drug since there is no current prevention drug.
Remember. They are applying for breakthrough once they have data.
I agree. I think something is going on...just a feeling. Or some of mgmt took summer vacations which they are fully obliged to do so.
BUP HAD GREAT DATA. BOM had great data. Small sample but very good and very lucrative. I would not be surprised if we all are soon to be surprised ;)
Plus, maybe P data is really good and being shown to nda holders. Discussions could be ramping up their.
Finally- Kevetrin. It has been several months to treat 5 patients for only3 weeks and 3 weeks of followup. This data could be extremely valuable and in the hands of nda big pharm.
Or Leo and Dr B are getting some R&R for what could be an epic fall
Ps- the last blog post was unique. Do you remember? It was posted a week prior to the data reveal the conference for about an hour and then pulled. And then put back up after the data reveal???? Interesting. Why?
It has happened and I fully expect it to happen here. It's awful quiet here. No PRs, no blogs.........tic toc imo.
Kevetrin could surprise us. The market and world could wake up overnight if these 5 patients are put into remission from this phase 2a
You never know.
That is the beautiful thing about trials. No one knows until the results are PRd and like the hundreds of bios before IPIX...one day the share price is $1 and you wake up one morning and the share price is $30 at opening bell.
It's quiet in IPIX land. Just let the trials keep rolling...Day in day out.
Data will come eventually. Good thing for us! IPIX has never failed or even come close to failing.
Their focus in 2017 is partnership. There is no deadline
Prurisol is 100% owned by IPIX! In a perfect world, I hope to see better than good numbers for Prurisol.
This in my mind will start a bidding war from cda holders quickly...as they will see data prior to anyone.
Sell P outright! Due to no profit sharing and the 505b2 which could extend exclusivity, I bet we could see upwards of 10 billion buyout. If the data is great! Jmo
That is a 60 plus share price just based on cash and no other drugs. FYI.
Crossing my fingers this scenario takes place...
I'm hoping for some Kevetrin update soon. Prurisol could be any day now too. It's nice to have so many drugs in the arsenal.
I can list so many posts by so many that mimic this here. They own the stock price right now. But!!!! They don't own the company. ATLEAST we have Leo and team. IPIX will MAXIMIZE shareholder value in the end, boooya.
It's very quiet friends........I got that feeling.....papers shuffling........ink drying............
I will say the board is super hard to stay engaged in tho. It's just all boring and nonsense. All the posters that hype are now talking trash etc.... get a life
Great day here! Hoping Kevetrin is living up to the dreams of patients
No need to hurry anything. Talks are getting hot! IMO.
Hand RAISED!!!!!! I know I know!!!!
The third quarter ends the day before Oct 1st!!!!!
Great article KarinCA! Thanks!
Zero. It's the companies goal to get to a point where partnership discussions are being had and phase 2 data will be the driver. Leo said that is currently where we are.
Strap in buddy